Search

Direct-to-consumer hearing devices: a need to combine cosmetic appeal with device capabilities

How safe and desirable are direct-to-consumer amplification devices? A team has put a range of devices through their paces and compared them to a standard NHS hearing device. Why do most individuals who would benefit from hearing aids not try...

Peter McKelvie 1932 – 2026

Peter McKelvie, an outstanding head & neck surgeon and oncologist, died on 6 February aged 93. He suffered a spontaneous subdural haemorrhage. British otolaryngology has lost the most remarkable talent of his generation. He combined a prodigious intellect with effortless...

Papzimeos: a major advance in treating adult recurrent respiratory papillomatosis

Since the beginning of our specialty, generations of patients and surgeons have faced the challenging clinical problem of recurrent respiratory papillomatosis (RRP). Driven by a persistent and chronic infection with low-risk human papillomavirus (HPV) types 6 or 11, it is...

Promoting human rights of deaf communities in low-resource settings

Stigma and misconceptions about deafness are serious impediments for many deaf people to realise rights and potential in some of the most challenging situations globally. Around 430 million people are estimated to live with moderate or higher levels of hearing...

Promoting human rights of deaf communities in low-resource settings

Stigma and misconceptions about deafness are serious impediments for many deaf people to realise rights and potential in some of the most challenging situations globally. Around 430 million people are estimated to live with moderate or higher levels of hearing...

Audiology and ophthalmology: a comparative perspective on diagnostics and patient care

What are the similarities and differences between audiology and ophthalmic practices, and what can we learn from each other? Rosalyn Painter finds out. I’m here with Chris Gordon and Anthony Vukic from Gloucestershire Hospitals NHS Foundation Trust to find out...

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...

Running a post-COVID smell clinic

Over the past year, much of our effort as a speciality has been directed towards crisis management and keeping services afloat. Our practice has changed in untold ways, but unprecedented numbers of patients with smell disorders will increasingly require our...

Wound moisture sensing in traumatic wounds

Wounds can be small and unpleasant, or may be large and life-threatening. The skin is a physical and an immunological barrier to infection, and any defect in the integrity of the skin may enable bacterial or fungal invasion. The successful...